Abstract
Aim: To investigate and analyze the current epidemiological and clinical data for
West syndrome (WS) in Korea, including treatments and outcome.
Methods: Prepared survey forms were sent to hospitals located all over Korea to collect
data on cases of WS treated between January 1997 and June 2000. Data from 21 institutes
were returned.
Results: Data were collected for 358 children (219 boys and 139 girls) who were diagnosed
and treated for WS. The incidences of WS were 112 cases in 1997, 104 cases in 1998,
108 cases in 1999, and 34 cases in the first half of 2000. Based on these figures,
the presumed annual incidence of WS in Korea was derived to be one in 4000 live births,
although there was a great inter-district variability. Regarding the etiology, 138
cases (38.5%) were cryptogenic. For the 220 symptomatic cases, hypoxic-ischemic encephalopathy
(HIE) was the most common etiologic factor (50.8%), followed by central nervous system
anomaly including malformation of cortical development (21.4%), and neurocutaneous
syndrome (8.6%). Clinically flexor type spasms were most common (59.2%) and 199 cases
(55.6%) revealed typical hypsarrhythmia, electroencephalographically.
During 1997 and 1998, vigabatrin (VGB) was used most frequently for the treatment
of WS, followed by valproic acid and adrenocorticotropic hormone (ACTH). In 1999 and
2000, the use of ACTH diminished and topiramate was used more frequently than ACTH.
Spasms were controlled in 230 cases (64.2%) and evolution to other seizure types was
observed in 44 cases (11.2%). Developmental and/or mental retardation were noticed
in 270 cases (75.4%).
Conclusions: The yearly incidence of WS did not show significant change in Korea between
1997 and 2000. Among symptomatic WS, HIE was the most common cause. During the period
of this study, VGB was the most popular therapeutic regimen possibly because of shortage
of ACTH. Recently, topiramate has showed promising signs as a therapy for WS.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Brain and DevelopmentAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- A case of Aicardi syndrome.J Korean Pediatr Soc. 1982; 25: 1285-1292
- EEG and CT findings of the West syndrome.J Korean Neurol Soc. 1984; 2: 94-102
- Clinical study on infantile spasm with ACTH therapy.J Korean Pediatr Soc. 1992; 35: 459-469
- Prognostic factors of infantile spasm.J Korean Child Neurol Soc. 1993; 1: 106-115
- Efficacy of ACTH treatment in infantile spasm: high-dose versus low-dose therapy.J Korean Child Neurol Soc. 1994; 2: 125-130
- West syndrome.J Korean Child Neurol Soc. 2000; 8: 8-26
- Infantile spasms.in: Wyllie E The treatment of epilepsy: principles and practice. 2nd ed. Williams and Wilkins, Baltimore, MD1997: 540-571
- The descriptive epidemiology of infantile spasms among Atlanta children.Epilepsia. 1999; 40: 748-751
- Occurrence, outcome, and prognostic factors of infantile spasms and Lennox–Gastaut syndrome.Epilepsia. 1999; 40: 286-289
- Epidemiology of infantile spasms in Sweden.Epilepsia. 1995; 36: 572-574
- Epidemiologic features of infantile spasms in Iceland.Epilepsia. 1994; 35: 802-805
- The epidemiology and natural history of infantile spasms.J Child Neurol. 1991; 6: 355-364
- Infantile spasms and West syndrome.in: Engel J Pedley T.A Epilepsy: a comprehensive textbook. Lippincott-Raven, Philadelphia, PA1997: 2277-2305
- Steroid or vigabatrin in the treatment of infantile spasms?.Pediatr Neurol. 2000; 23: 403-408
- A pilot study of topiramate in the treatment of infantile spasms.Epilepsia. 1998; 29: 1324-1328
- Long-term response to topiramate in patients with West syndrome.Epilepsia. 2000; 41: S91-S94
- Efficacy of the ketogenic diet for intractable seizure disorders: review of 58 cases.Epilepsia. 1992; 33: 1132-1136
- Current therapy for West syndrome in Japan.J Child Neurol. 2000; 15: 424-428
- Long-term prognosis of 150 cases of ‘West syndrome’.Epilepsia. 1973; 14: 153-164
- Mental outcome in West syndrome: prognostic value of some clinical factors.J Ment Defic Res. 1987; 31: 9-15
Article info
Publication history
Accepted:
August 19,
2001
Received in revised form:
July 16,
2001
Received:
May 30,
2001
Identification
Copyright
© 2001 Elsevier Science B.V. Published by Elsevier Inc. All rights reserved.
